Anticoagulant News and Research

RSS
Deep vein clots in critical COVID-19 illness

Deep vein clots in critical COVID-19 illness

Heparin resistance among COVID-19 patients admitted to ICU

Heparin resistance among COVID-19 patients admitted to ICU

Fewer COVID-19 patients suffer from stroke than previously reported

Fewer COVID-19 patients suffer from stroke than previously reported

COVID-19 associated with high thrombotic risk

COVID-19 associated with high thrombotic risk

Study highlights need to focus on medications that address clot formation

Study highlights need to focus on medications that address clot formation

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

COVID-19 patients at high risk for developing complications associated with blood clots

COVID-19 patients at high risk for developing complications associated with blood clots

SARS-CoV-2 binds heparan sulfate, preventing host cell infection

SARS-CoV-2 binds heparan sulfate, preventing host cell infection

Study provides indications and techniques of lower extremity revascularization

Study provides indications and techniques of lower extremity revascularization

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Study reveals antiviral properties of glycosaminoglycans against SARS-CoV-2

Study reveals antiviral properties of glycosaminoglycans against SARS-CoV-2

Low molecular weight heparins inhibit SARS-CoV-2 cell invasion

Low molecular weight heparins inhibit SARS-CoV-2 cell invasion

AAN publishes updated practice advisory on closure of common heart defect after stroke

AAN publishes updated practice advisory on closure of common heart defect after stroke

Trial assesses tissue plasminogen activator as a treatment for COVID-19-related respiratory failure

Trial assesses tissue plasminogen activator as a treatment for COVID-19-related respiratory failure

Excess cardiac myosin worsens damage to heart tissue during a heart attack

Excess cardiac myosin worsens damage to heart tissue during a heart attack

Pancreatitis drug Nafamostat shows promise for coronavirus

Pancreatitis drug Nafamostat shows promise for coronavirus

CVIA publishes new issue that brings key research papers from top cardiologists

CVIA publishes new issue that brings key research papers from top cardiologists

Direct oral anticoagulant more effective in lowering risk of VTE after common orthopedic surgeries

Direct oral anticoagulant more effective in lowering risk of VTE after common orthopedic surgeries

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Adding antiplatelet therapy to oral anticoagulants raises risk for TAVR patients with atrial fibrillation

Adding antiplatelet therapy to oral anticoagulants raises risk for TAVR patients with atrial fibrillation